| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |